By Katie Gu
Mifepristone’s shifting legal terrain may soon raise new privacy considerations regarding telemedicine data collection, security, and disclosure.
The Mifepristone Debates
Mifepristone is the first medication of a two-part drug regime that accounts for approximately half of legal abortions in the United States. Since its original U.S. Food and Drug Administration (FDA) approval